300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Liberia
Lesotho
Isle of Man
Nepal
Malawi
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Guatemala
Jamaica
Kazakhstan
Cayman Islands
Switzerland
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Ireland
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Portugal
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Bahamas
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Empirical Ventures, VC Fund

Empirical Ventures

VC Fund

Bristol, United Kingdom

Empirical Ventures is a VC fund in Bristol focused on Biotechnology and Medical. Empirical Ventures supports innovative approaches to critical problems in the fields of biotechnology and life sciences.

Total investments:
40
Last investment:
Lead investor:
33%
Fund size:
$10M
Last fund:

Last updated:

Industries Empirical Ventures invests in

BiotechnologyMedicalHealth CareMedical DeviceAgTech

Stages Empirical Ventures invests in

SeedPre-SeedFunding RoundGrantSeries A

Countries Empirical Ventures invests in

United Kingdom

Round sizes

Seed $924k–$5.8MPre-Seed $1.1M–$1.6M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$924k–$5.8M
Pre-Seed
$1.1M–$1.6M

Investment Focus

Industry

  • Biotechnology 7 (18%)
  • Medical 6 (15%)
  • Health Care 4 (10%)
  • Medical Device 4 (10%)
  • AgTech 2 (5%)
See all 41 industries →

Stage

  • Seed 25 (63%)
  • Pre-Seed 2 (5%)
  • Funding Round 2 (5%)
  • Grant 1 (3%)
  • Series A 1 (3%)
See all 6 stages →

Team

NameTitleInvestmentsLinksEmail
Jonathan Matlock
Jonathan Matlock Co-Founder
Co-Founder Total investments: 12
Find email
Johnathan Matlock
Johnathan Matlock Co-Founder
Co-Founder Total investments: 9
Find email

Investments

CompanyDescriptionRoundLinks
OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine. $67.7K / Grant / Sep 08, 2026
Nuclear Turbines is an energy firm that is creating tiny modular nuclear technologies to make clean nuclear power more affordable than fossil fuels. $20M / Seed / Jul 27, 2026
Healome Therapeutics
Healome Therapeutics $2.7M / Seed / Jul 07, 2026
Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP. $4M / Seed / Jun 30, 2026
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market. $6.6M / Series A / Jun 17, 2026
Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics. $5.8M / Seed / May 27, 2026
Fermtech provides equipment for precision fermentation companies to scale production processes. Fermtech was founded in 2022 and was headquartered in Oxford, England. $3.3M / Seed / Apr 07, 2026
Orthofuse is a medtech company that provides orthopaedic solutions using 3D-printed implant systems designed to improve the safety and efficiency of surgical procedures. $3M / Seed / Feb 12, 2026
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients. $6M / Jan 21, 2026
HotGreen is an industrial high-temperature heat pump company providing process heat from electricity. $1.6M / Pre-Seed / Oct 14, 2025
See all 40 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Liberia
Lesotho
Isle of Man
Nepal
Malawi
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Guatemala
Jamaica
Kazakhstan
Cayman Islands
Switzerland
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Ireland
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Portugal
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Bahamas
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Empirical Ventures invest in?

Empirical Ventures invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 40 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Empirical Ventures's check size?

Empirical Ventures typically joins rounds of $924k–$5.8M at Seed and $1.1M–$1.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Empirical Ventures participates in.

How do I contact Empirical Ventures?

Public channels for Empirical Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Empirical Ventures?

The team at Empirical Ventures includes Jonathan Matlock (Co-Founder) and Johnathan Matlock (Co-Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Empirical Ventures Empirical Ventures Find emails